HUT62896A - Process for producing new trans-cyclopentanylpurine analogs having immunosuppressant activity and pharmaceutical compositions comprising same as active ingredient - Google Patents

Process for producing new trans-cyclopentanylpurine analogs having immunosuppressant activity and pharmaceutical compositions comprising same as active ingredient

Info

Publication number
HUT62896A
HUT62896A HU929203858A HU9203858A HUT62896A HU T62896 A HUT62896 A HU T62896A HU 929203858 A HU929203858 A HU 929203858A HU 9203858 A HU9203858 A HU 9203858A HU T62896 A HUT62896 A HU T62896A
Authority
HU
Hungary
Prior art keywords
analogs
cyclopentanylpurine
active ingredient
pharmaceutical compositions
same
Prior art date
Application number
HU929203858A
Other languages
English (en)
Other versions
HU217077B (hu
Inventor
David Roger Borcherding
Carl Keith Edwards
Ronald Eugene Esser
Douglas Leon Cole
Original Assignee
Marion Merrell Dow Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marion Merrell Dow Inc filed Critical Marion Merrell Dow Inc
Publication of HUT62896A publication Critical patent/HUT62896A/hu
Publication of HU217077B publication Critical patent/HU217077B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9203858A 1991-12-06 1992-12-04 Eljárás immunoszupresszáns hatású transz-ciklopentanil-purin-analógok és ezeket tartalmazó gyógyszerkészítmények előállítására HU217077B (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80415391A 1991-12-06 1991-12-06
US96560192A 1992-11-02 1992-11-02

Publications (2)

Publication Number Publication Date
HUT62896A true HUT62896A (en) 1993-06-28
HU217077B HU217077B (hu) 1999-11-29

Family

ID=27122672

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9203858A HU217077B (hu) 1991-12-06 1992-12-04 Eljárás immunoszupresszáns hatású transz-ciklopentanil-purin-analógok és ezeket tartalmazó gyógyszerkészítmények előállítására
HU9203858A HU9203858D0 (en) 1991-12-06 1992-12-04 New trans-cyclopentanyl-purine analogues having immuno suppressing effect

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9203858A HU9203858D0 (en) 1991-12-06 1992-12-04 New trans-cyclopentanyl-purine analogues having immuno suppressing effect

Country Status (17)

Country Link
EP (1) EP0545413B1 (hu)
JP (1) JP3264289B2 (hu)
KR (1) KR100251996B1 (hu)
AT (1) ATE194618T1 (hu)
AU (1) AU658698B2 (hu)
CA (1) CA2084222C (hu)
DE (1) DE69231242T2 (hu)
DK (1) DK0545413T3 (hu)
ES (1) ES2149163T3 (hu)
FI (1) FI109026B (hu)
GR (1) GR3034586T3 (hu)
HU (2) HU217077B (hu)
IL (1) IL103962A (hu)
MX (1) MX9206963A (hu)
NO (1) NO305207B1 (hu)
NZ (1) NZ245342A (hu)
PT (1) PT545413E (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103131T3 (es) 1993-06-21 1997-08-16 Merrell Pharma Inc Nuevos agentes de nucleosido carbociclico utiles como inhibidores selectivos de citoquinas proinflamatorias.
TW552261B (en) * 1996-07-03 2003-09-11 Japan Energy Corp Novel purine derivative
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
US6413974B1 (en) 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
FR2793794B1 (fr) * 1999-05-21 2001-07-27 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
US6861524B2 (en) 2000-10-31 2005-03-01 Aventis Pharmaceuticals Inc. Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038479A (en) * 1969-11-17 1977-07-26 Burroughs Wellcome Co. Amino purine derivatives
US4076711A (en) * 1976-04-05 1978-02-28 Schering Corporation Triazolo [4,5-d]-pyrimidines
CA2001715C (en) * 1988-11-14 1999-12-28 Muzammil M. Mansuri Carbocyclic nucleosides and nucleotides
ATE133678T1 (de) * 1990-07-04 1996-02-15 Merrell Dow Pharma 9-purinyl-phosphonsäurederivate
AU647822B2 (en) * 1990-09-14 1994-03-31 Marion Merrell Dow Inc. Novel carbocyclic adenosine analogs useful as immunosuppressants

Also Published As

Publication number Publication date
DE69231242T2 (de) 2000-12-21
IL103962A (en) 1997-01-10
FI925520A0 (fi) 1992-12-04
JP3264289B2 (ja) 2002-03-11
AU2975292A (en) 1993-06-10
EP0545413A1 (en) 1993-06-09
NO924691D0 (no) 1992-12-04
ATE194618T1 (de) 2000-07-15
IL103962A0 (en) 1993-05-13
DE69231242D1 (de) 2000-08-17
CA2084222C (en) 2004-04-06
PT545413E (pt) 2000-10-31
AU658698B2 (en) 1995-04-27
ES2149163T3 (es) 2000-11-01
HU217077B (hu) 1999-11-29
MX9206963A (es) 1993-06-01
CA2084222A1 (en) 1993-06-07
DK0545413T3 (da) 2000-10-09
FI109026B (fi) 2002-05-15
HU9203858D0 (en) 1993-03-29
FI925520L (fi) 1993-06-07
GR3034586T3 (en) 2001-01-31
NZ245342A (en) 1995-10-26
NO924691L (no) 1993-06-07
JPH0656835A (ja) 1994-03-01
NO305207B1 (no) 1999-04-19
EP0545413B1 (en) 2000-07-12
KR100251996B1 (ko) 2000-09-01

Similar Documents

Publication Publication Date Title
HUP0001760A2 (hu) Aril-acil-piridazin-származékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és a vegyületek alkalmazása gyógyszerkészítmények előállítására
EP0269574A3 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
MY100574A (en) 5-substituted-2-cyclopropyl-6, 8-difluoroquinoline derivatives and processes for preparation thereof
IL132208A0 (en) 2-Aminopropane- 1,3-diol derivatives and pharmaceutical compositions containing the same
MY101748A (en) Novel 8-chloro-1, 5-benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions.
HUT65935A (en) Process for producing triazolopyridazine derivatives and pharmaceutical preparations containing them as active ingredients
MY103801A (en) Dideoxydidehydrocarbocyclic nucleosides
HUT46313A (en) Process for producing 3/2h/-pyridazine derivatives and pharmaceutical compositions containing them as active components
HUP0004359A2 (hu) Kondenzált pirazinszármazékok és ezeket tartalmazó gyógyászati készítmények
HUT59151A (en) Process for producing purinylphosphonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
IE64864B1 (en) Novel 2-substituted ergoline derivatives processes for their preparation and use thereof as medicinal agents
FR2593504B1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
CA2051012A1 (en) Carbocyclic adenosine analogs useful as immunosupressants
IL103962A (en) Trans 9(3-hydroxy-cyclopentan-1-yl) purine analogs their preparation and immunosuppressant pharmaceutical compositions containing them
GR3007401T3 (hu)
ES8706144A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
ES2019840A6 (es) Procedimiento para preparar nuevos derivados de tieno-triazolo-diazepina.
HUP9701984A1 (hu) 3-Amido-kromanil-szulfonil-tio-karbamid-származékok, eljárás az előállításukra, valamint a vegyületeket tartalmazó gyógyászati készítmények
MD1449G2 (ro) Derivaţi ai 2-amino-1,2,3,4-tetrahidronaftalinei cu acţiune asupra sistemului cardiovascular, procedeu de obţinere a acestora şi compoziţii farmaceutice care îi conţin
MY102310A (en) New 5-oxy deravatives of tetrahydrofuran
EP0475413A3 (en) Carbocyclic nucleoside analogs useful as immunosuppressants
CA2253914A1 (en) Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
GEP19960472B (en) Method of producing derivative of quinoline or its pharmaceutically acceptable ester, or their salts
RU94031211A (ru) Производные изатина, способ их получения и фармацевтическая композиция на их основе
CA2156079A1 (en) Novel derivatives of 3-hydroxy anthranilic acid, methods and intermediates for their preparation, novel pharmaceutial compositions and the use thereof

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee